Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial

BACKGROUND: Silymarin is a flavonoid complex with nephro-protective properties. We evaluated the efficacy of silymarin in the prevention of contrast-induced nephropathy (CIN). METHODS: This placebo-controlled clinical trial was conducted on 143 patients with chronic stable angina referring for elect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sedighifard, Zohreh, Roghani, Farshad, Bidram, Peyman, Harandi, Samaneh Aalami, Molavi, Safieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755255/
https://www.ncbi.nlm.nih.gov/pubmed/26941924
http://dx.doi.org/10.4103/2008-7802.174762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755255/
https://www.ncbi.nlm.nih.gov/pubmed/26941924
http://dx.doi.org/10.4103/2008-7802.174762

Ejemplares similares